Ansell (ANN) AGM 2024 summary

Opening remarks and agenda

• Chair welcomed attendees, acknowledged traditional land owners, and outlined meeting procedures for both in-person and virtual participants.

• Voting and question submission processes were explained, ensuring shareholder engagement and transparency.

• Quorum was confirmed, and the meeting was declared open with voting on all items available throughout.

Financial performance review

• FY24 adjusted EPS was 105.5 US¢, within guidance; statutory EPS fell 46.3% to 59.4 US¢.

• FY24 sales reached $1,619.3m, down 2.9% in constant currency; GPADE margin improved to 31.9% (+150bps).

• Industrial segment saw sales and earnings growth, achieving its highest-ever EBIT margin, while healthcare segment faced headwinds from customer destocking and shipping disruptions.

• Operating cash flow was $167.9m; working capital reduced by $105m, with inventory down $68m.

• Cash conversion rate was 131%, reflecting strong operational efficiency.

Strategic initiatives and plans

• Accelerated Productivity Investment Program delivered $28m in FY24 savings, targeting $50m annualised by FY26.

• Organisational restructuring completed, including headcount reduction and streamlined executive team.

• KBU (Kimberly-Clark PPE) acquisition enhances growth in scientific verticals, expands product portfolio, and targets $10m run-rate cost synergies by year 3.

• IT digitisation strategy underway, with global ERP rollout planned to begin in FY26 and complete by FY27.

• Sustainability initiatives advanced, including Science Based Targets, supply chain engagement, waste reduction, and product innovation in recyclability and compostability.